Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden

References

• Klein JO. The epidemiology of pneumococcal disease in infants and children. Rev Infect Dis 1981; 3: 246–53
   PubMedGoogle Scholar
• Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use; part II. Clin Infect Dis 2000; 30: 122–40
   PubMed Web of Science ®Google Scholar
• Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000; 19: 187–95
   PubMed Web of Science ®Google Scholar
• Black SB, Shinefield HR, Ling S, Hansen J, Fireman B, Spring D, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 y of age for prevention of pneumonia. Pediatr Infect Dis J 2002; 21: 810–5
   PubMed Web of Science ®Google Scholar
• Hansen J, Black S, Shinefield H, Cherian T, Benson J, Fireman B, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 y of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J 2006; 25: 779–81
   PubMed Web of Science ®Google Scholar
• Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344: 403–9
   PubMed Web of Science ®Google Scholar
• Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737–46
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunization with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007; 369: 1179–86
   PubMed Web of Science ®Google Scholar
• McIntosh ED, Conway P, Willingham J, Lloyd A. The cost burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine. Vaccine 2003; 21: 2564–72
   PubMed Web of Science ®Google Scholar
• Wisloff T, Abrahamsen TG, Bergsaker MA, Lovoll O, Moller P, Pedersen MK, Kristiansen IS. Cost-effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination programme. Vaccine 2006;24:5690–9, Epub 2006, May 5.
   PubMed Web of Science ®Google Scholar
• Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, et al. Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006; 368: 1495–502
   PubMed Web of Science ®Google Scholar
• Dahl MS, Trollfors B, Claesson BA, Brandberg LL, Rosengren A. Invasive pneumococcal infections in south-western Sweden: a second follow-up period of 15 y. Scand J Infect Dis 2001; 33: 667–72
   PubMedGoogle Scholar
• Brandenburg JA, Marrie TJ, Coley CM, Singer DE, Obrosky DS, Kapoor WN, Fine MJ. Clinical presentation: processes and outcomes of care for patients with pneumococcal pneumonia. J Gen Intern Med 2000; 15: 638–46
   PubMed Web of Science ®Google Scholar
• Joki-Erkkila VP, Laippala P, Pukander J. Increase in paediatric acute otitis media diagnosed by primary care in 2 Finnish municipalities:1994–1995 versus 1978–1979. Epidemiol Infect 1998; 121: 529–34
   PubMed Web of Science ®Google Scholar
• Treatment for acute inflammation of the middle ear, Programme and Lectures. Consensus development conference, May 10–12, 2000. ( Landstingsförbundet. Medicinska forskningsrådet. Socialstyrelsen)
   Google Scholar
• Sade J, Russo E, Fuchs C, Cohen D. Is secretory otitis media a single disease entity?. Ann Otol Rhinol Laryngol 2003; 112: 342–7
   PubMed Web of Science ®Google Scholar
• Vassbotn FS., Klausen OG., Lind O., Moller P. Acute mastoiditis in a Norwegian population: a 20-y retrospective study. Int J Pediatr Otorhinolaryngol 2002; 62: 237–42
   PubMed Web of Science ®Google Scholar
• Straetemans M, Palmu A, Auranen K, Zielhuis GA, Kilpi T. The effect of a pneumococcal conjugate vaccine on the risk of otitis media with effusion at 7 and 24 months of age. Int J Pediatr Otorhinolaryngol 2003; 67: 1235–42
   PubMed Web of Science ®Google Scholar
• Wisloff T, Abrahamsen TG, Bergsaker MA, Lovoll O, Moller P, Pedersen MK, Kristiansen IS. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination programme. Technical report. 2005.
   Google Scholar
• Hedlund J, Sorberg M, Henriques-Normark B, Kronvall G. Capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae among children in Sweden. Scand J Infect Dis 2003; 35: 452–8
   PubMed Web of Science ®Google Scholar
• Harvard Centre for Risk Analysis. http://www.hsph.harvard.edu/cearegistry. 2005
   Google Scholar
• Salo H, Sintonen H, Nuorti JP, Linna M, Nohynek H, Verho J, Kilpi T. Economic evaluation of pneumococcal conjugate vaccination in Finland. Scand J Infect Dis 2005; 37: 821–32
   PubMed Web of Science ®Google Scholar
• Swedish Statistics, http://www.scb.se/templates/Lönedatabasen/Lonedatabasen_ infobox.asp?id=50918&yid=323 &Yrke=sjuksköterska.
   Google Scholar
• Neumark T, Mölstad S, Rosén C, Persson LG, Törngren A, Brudin L, , et al Evaluation of phenoxymethylpencillin treatment of acute otitis media in children aged 2–16 y. (Forthcoming).
   Google Scholar
• Hjalte K, Hjelmgren J, Johansson F, Perssoon U. Betalningsviljan för ett kvalitetsjusterat levnadsår- en pilotstudie. IHE e- rapport 2005:1.
   Google Scholar
• Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. Br Med J 2004; 329: 224–7
   PubMed Web of Science ®Google Scholar
• Persson U, Hjelmgren J. Hälso- och sjukvården behöver kunskap om hur befolkningen värderar hälsan. Läkartidningen 2003; 43: 3436–7
   Google Scholar
• Beutels P, Thiry N, van Damme P. Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination: a review (2002–2006). Vaccine 2007; 25: 1355–67
   PubMed Web of Science ®Google Scholar